Connection
Susan Smyth to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Susan Smyth has written about Platelet Aggregation Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
3.622 |
|
|
|
-
Gross AK, Dunn SP, Feola DJ, Martin CA, Charnigo R, Li Z, Abdel-Latif A, Smyth SS. Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J Thromb Thrombolysis. 2013 Feb; 35(2):147-54.
Score: 0.413
-
Smyth SS. Anti-platelet therapy. Curr Drug Targets. 2011 Nov; 12(12):1790-1.
Score: 0.379
-
Bailey AL, Scantlebury DC, Smyth SS. Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol. 2009 Mar; 29(3):284-8.
Score: 0.314
-
Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, Steinhubl SR, Becker RC. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009 Apr; 29(4):449-57.
Score: 0.309
-
Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, Colby E, Montague D, Smyth SS. Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother. 2007 May; 41(5):737-41.
Score: 0.277
-
Lee JS, Dunn SP, Marshall HM, Cohen MG, Smyth SS. A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance. Clin Cardiol. 2007 Apr; 30(4):200-3.
Score: 0.276
-
Becker RC, Sexton T, Smyth SS. Translational Implications of Platelets as Vascular First Responders. Circ Res. 2018 02 02; 122(3):506-522.
Score: 0.146
-
Beavers CJ, Heron P, Smyth SS, Bain JA, Macaulay TE. Obesity and Antiplatelets-Does One Size Fit All? Thromb Res. 2015 Oct; 136(4):712-6.
Score: 0.122
-
Steinhubl SR, Eikelboom JW, Hylek EM, Dauerman HL, Smyth SS, Becker RC. Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. J Thromb Thrombolysis. 2014 Apr; 37(3):362-71.
Score: 0.112
-
Bledzka K, Smyth SS, Plow EF. Integrin aIIbß3: from discovery to efficacious therapeutic target. Circ Res. 2013 Apr 12; 112(8):1189-200.
Score: 0.105
-
Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, Gartner TK, Smyth SS, Li Z. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism. PLoS One. 2012; 7(12):e51037.
Score: 0.102
-
Abdel-Latif A, Smyth SS. Preventing platelet thrombosis with a PAR1 pepducin. Circulation. 2012 Jul 03; 126(1):13-5.
Score: 0.099
-
Wang TY, Angiolillo DJ, Cushman M, Sabatine MS, Bray PF, Smyth SS, Dauerman HL, French PA, Becker RC. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. J Am Coll Cardiol. 2012 Mar 06; 59(10):891-900.
Score: 0.097
-
Bailey AL, Smyth SS, Campbell CL. The case against routine aspirin use for primary prevention in low-risk adults. Am Fam Physician. 2011 Jun 15; 83(12):1387-90.
Score: 0.092
-
Smyth SS. Platelets unplugged: an ATVB special series focused on platelet biology. Arterioscler Thromb Vasc Biol. 2010 Dec; 30(12):2339-40.
Score: 0.089
-
Williams MS, Weiss EJ, Sabatine MS, Simon DI, Bahou WF, Becker LC, Parise LV, Dauerman HL, French PA, Smyth SS, Becker RC. Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol. 2010 Dec; 30(12):2372-84.
Score: 0.089
-
Dauerman HL, Bhatt DL, Gretler DD, French PA, Smyth SS, Becker RC. Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients. Am Heart J. 2010 Apr; 159(4):508-517.e1.
Score: 0.085
-
Becker RC, Smyth S. The evolution of platelet-directed pharmacotherapy. J Thromb Haemost. 2009 Jul; 7 Suppl 1:266-71.
Score: 0.081
-
Oestreich JH, Holt J, Dunn SP, Smyth SS, Campbell CL, Charnigo R, Akers WS, Steinhubl SR. Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coron Artery Dis. 2009 May; 20(3):207-13.
Score: 0.080
-
Oestreich JH, Smyth SS, Campbell CL. Platelet function analysis: at the edge of meaning. Thromb Haemost. 2009 Feb; 101(2):217-9.
Score: 0.078
-
Smyth SS, Monroe DM, Wysokinski WE, McBane RD, Whiteheart SW, Becker RC, Steinhubl SR. Platelet activation and its patient-specific consequences. Thromb Res. 2008; 122(4):435-41.
Score: 0.072
-
Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 2007 May 09; 297(18):2018-24.
Score: 0.069
-
Palmerini T, Nedelman MA, Scudder LE, Nakada MT, Jordan RE, Smyth S, Gordon RE, Fallon JT, Coller BS. Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. J Am Coll Cardiol. 2002 Jul 17; 40(2):360-6.
Score: 0.050
-
Abo-Aly M, George B, Shokri E, Chelvarajan L, El-Helw M, Smyth SS, Abdel-Latif A, Ziada K. Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2021 Oct; 52(3):934-940.
Score: 0.044
-
Moliterno DJ, Smyth SS, Abdel-Latif A. CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All. JAMA. 2020 08 25; 324(8):747-749.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|